Regulatory T cells phenotype in different clinical forms of chagas' disease

PLoS Neglected Tropical Diseases

Volumn 5, Issue 5, 2011, Pages

  de Araújo, Fernanda Fortes ^a   Vitelli Avelar, Danielle Marquete ^a   Teixeira Carvalho, Andréa ^a   Antas, Paulo Renato Zuquim ^a   Gomes, Juliana Assis Silva ^a,b   Sathler Avelar, Renato ^a   Rocha, Manoel Otávio Costa ^b   Elói Santos, Silvana Maria ^a,b   Pinho, Rosa Teixeira ^a   Correa Oliveira, Rodrigo ^a,c   Martins Filho, Olindo Assis ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c National Institute of Petroleum Geophysics   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; HUMAN; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; TISSUE INJURY; TRYPANOSOMA CRUZI; CHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY;

ANTIGENS, CD; CHAGAS DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; T-LYMPHOCYTES, REGULATORY; TRYPANOSOMA CRUZI;

EID: 79958000981     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000992     Document Type: Review

References (65)

1. Reis DD, Jones EM, Tostes JR, Lopes ER, Gazzinelli G, et al. (1993) Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48: 637-644.
2. Bahia-Oliveira LM, Gomes JA, Cancado JR, Ferrari TC, Lemos EM, et al. (2000) Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J Infect Dis 182: 634-638.
3. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, et al. (2003) Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
4. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, et al. (2005) Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960-7966.
5. Dutra WO, Gollob KJ, Pinto-Dias JC, Gazzinelli G, Correa-Oliveira R, et al. (1997) Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 45: 74-80.
6. Dutra WO, Rocha MO, Teixeira MM, (2005) The clinical immunology of human Chagas' disease. Trends Parasitol 21: 581-587.
7. Dutra WO, Menezes CA, Villani FN, da Costa GC, da Silveira AB, et al. (2009) Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas' disease. Mem Inst Oswaldo Cruz 104 (Suppl 1): 208-218.
8. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, et al. (2004) Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 72: 5283-5291.
9. Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho A, et al. (2005) Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand J Immunol 62: 297-308.
10. Vitelli-Avelar DM, Sathler-Avelar R, Massara RL, Borges JD, Lage PS, et al. (2006) Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol 145: 81-92.
11. Vitelli-Avelar DM, Sathler-Avelar R, Teixeira-Carvalho A, Pinto Dias JC, Gontijo ED, et al. (2008) Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas' disease. Scand J Immunol 68: 516-525.
12. Araújo-Jorge TC, Waghabi MC, Soeiro MN, Keramidas M, Bailly S, et al. (2008) Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. Cytokine Growth Factor Rev 19: 405-413.
13. Sathler-Avelar R, Vitelli-Avelar DM, Teixeira-Carvalho A, Martins-Filho OA, (2009) Innate immunity and regulatory T-cells in human Chagas' disease: what must be understood? Mem Inst Oswaldo Cruz 104 (Suppl 1): 246-251.
14. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
15. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA, (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167: 1245-1253.
16. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
17. Mills KH, (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
18. Belkaid Y, Rouse BT, (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360.
19. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN, (2007) Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82: 1365-1374.
20. Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, et al. (2007) Potential role of CD4+CD25High regulatory T cells in morbidity in Chagas' disease. Front Biosci 12: 2797-2806.
21. da Silveira AB, Araújo FF, Freitas MA, Gomes JA, Chaves AT, et al. (2009) Characterization of the presence and distribution of Foxp3(+) cells in chagasic patients with and without megacolon. Hum Immunol 70: 65-67.
22. Weekly ER, (2007) New global efforts to eliminate Chagas' disease. Epidemiol Records 82: 259-260.
23. Dias JC, (1989) The indeterminate form of human chronic Chagas' disease: a clinical epidemiological review. Rev Soc Bras Med Trop 22: 147-156.
24. Umezawa ES, Stolf AM, Corbett CE, Shikanai-Yasuda MA, (2002) Chagas' disease. Lancet 359: 627.
25. Rocha MO, Teixeira MM, Ribeiro AL, (2007) An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 5: 727-743.
26. Gazzinelli RT, Gazzinelli G, Cançado JR, Cardoso JE, Brener Z, et al. (1990) Two modes of idiotypic stimulation of T lymphocytes from patients with Chagas' disease: correlations with clinical forms of infection. Res Immunol 141: 757-770.
27. Higuchi MD, Reis MM, Aiello VD, Benvenuti LA, Gutierrez PS, et al. (1997) Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
28. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, et al. (2001) Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 17: 99-107.
29. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, et al. (2004) Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950.
30. Laucella SA, Postan M, Martin D, Hubby-Fralish B, Albareda MC, et al. (2004) Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas' disease. J Infect Dis 189: 909-918.
31. Fonseca SG, Moins-Teisserenc H, Clave E, Ianni B, Nunes VL, et al. (2005) Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect 7: 688-697.
32. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, et al. (2006) Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39: 41-54.
33. Bilate AM, Cunha-Neto E, (2008) Chagas' disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop Sao Paulo 50: 67-74.
34. Costa GC, Rocha MO, Moreira PR, Menezes CA, Silva MR, et al. (2009) Functional IL-10 gene polymorphism is associated with Chagas' disease cardiomyopathy. J Infect Dis 199: 451-454.
35. Kinter AL, Hennessey M, Bell A, Kern S, Lin Y, et al. (2004) CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200: 331-343.
36. Liu G, Zhao Y, (2007) Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122: 149-156.
37. Barros-Mazon S, Guariento ME, da Silva CA, Coffman RL, Abrahamsohn IA, (2004) Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas' disease. Clin Immunol 111: 137-145.
38. Souza PE, Rocha MO, Menezes CA, Coelho JS, Chaves AC, et al. (2007) Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Infect Immun 75: 1886-1894.
39. Menezes CA, Rocha MO, Souza PE, Chaves AC, Gollob KJ, et al. (2004) Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 137: 129-138.
40. Rivera MT, De Souza AP, Araujo-Jorge TC, De Castro SL, Vanderpas J, (2003) Trace elements, innate immune response and parasites. Clin Chem Lab Med 41: 1020-1025.
41. Andrade LO, Machado CR, Chiari E, Pena SD, Macedo AM, (2002) Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations. Exp Parasitol 100: 269-275.
42. Costa GC, Rocha MO, Moreira PR, Menezes CA, Silva MR, et al. (2009) Functional IL-10 gene polymorphism is associated with Chagas' disease cardiomyopathy. J Infect Dis 199: 451-454.
43. Freitas JM, Andrade LO, Pires SF, Lima R, Chiari E, et al. (2009) The MHC gene region of murine hosts influences the differential tissue tropism of infecting Trypanosoma cruzi strains. PLoS ONE 4: e5113 doi:10.1371/journal.pone.0005113.
44. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG, (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2: 1126-1132.
45. Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, et al. (2002) Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes. J Exp Med 196: 379-387.
46. Iellem A, Colantonio L, De Ambrosio D, (2003) Skin versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur J Immunol 33: 1488-1496.
47. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, et al. (2004) Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 199: 303-313.
48. Piccirillo CA, (2008) Regulatory T cells in health and disease. Cytokine 43: 395-401.
49. Campbell DJ, Ziegler SF, (2007) FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 7: 305-310.
50. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4: 330-336.
51. Khattri R, Cox T, Yasayko SA, Ramsdell F, (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342.
52. Hori S, Sakaguchi S, (2004) Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 6: 745-751.
53. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
54. Ramsdell F, (2003) FOXP3 and natural regulatory T cells: key to a cell lineage? Immunity 19: 165-168.
55. Read S, Malmstrom V, Powrie F, (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302.
56. Winstead CJ, Fraser JM, Khoruts A, (2008) Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J Immunol 180: 7305-7317.
57. Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, et al. (1999) CTLA-4- mediated inhibition of early events of T-cell proliferation. J Immunol 162: 5813-5820.
58. Blair PJ, Riley JL, Levine BL, Lee KP, Craighead N, et al. (1998) CTLA-4 binding delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J Immunol 160: 12-15.
59. Alegre ML, Shiels H, Thompson CB, Gajewski TF, (1998) Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol 161: 3347-3356.
60. Saverino D, Merlo A, Bruno S, Pistoia V, Grossi CE, et al. (2002) Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol 168: 207-215.
61. Laurent S, Carrega P, Saverino D, Piccioli P, Camoriano M, et al. (2010) CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. Human Immunol 71: 934-941.
62. Coquerelle C, Oldenhove G, Acolty V, Denoeud J, Vansanten G, et al. (2009) Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. Gut 58: 1363-1373.
63. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, et al. (2001) IL.10 is required for T cells to mediate tolerance to alloantigens in vivo. J Immunol 166: 3789-3796.
64. Higuchi ML, Gutierrez PS, Aiello VD, Palomino S, Bocchi E, et al. (1993) Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 423: 157-160.
65. Lieke T, Graefe SE, Klauenberg U, Fleischer B, Jacobs T, (2004) NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect Immun 72: 6817-6825.